Matthew Downs

1.5k citations

10 papers · 707 indexed · h-index 6

Impact in

Virology top 5%
- HIV Research and Treatment
Oncology top 10%
- CAR-T cell therapy research

Papers in ⓘ

Otorhinolaryngology 2
- Head and Neck Cancer Studies 2
Virology 2
- HIV Research and Treatment 2

Co-authors: Margo R. Roberts (2 shared papers)Peter A. Anton (2 shared papers)Steven G. Deeks (2 shared papers)Carl H. June (2 shared papers)Andreas Bakker (2 shared papers)David T. Scadden (2 shared papers)Andy Lin (2 shared papers)Kristen Hege (2 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (2 papers)Blood (2 papers)Clinical Infectious Diseases (1 paper)Ophthalmology (1 paper)The Lancet Child & Adolescent Health (1 paper)
Partner nations: United States Canada Tunisia

In The Last Decade

Matthew Downs

10 papers receiving 694 citations

Peers

Countries citing papers authored by Matthew Downs

Since Specialization

Citations

This map shows the geographic impact of Matthew Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Downs more than expected).

Fields of papers citing papers by Matthew Downs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Downs. The network helps show where Matthew Downs may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Downs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Downs Line = papers co-authored together Matthew Downs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work
1	Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects Blood ·Ronald T. Mitsuyasu, Peter A. Anton, Steven G. Deeks, David T. Scadden, Elizabeth Connick, Matthew Downs, Andreas Bakker, Margo R. Roberts, Carl H. June, Sayeh Jalali, Andy Lin, Rukmini Pennathur-Das, Kristen Hege	2000	335
2	Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects Blood ·Ronald T. Mitsuyasu, Peter A. Anton, Steven G. Deeks, David T. Scadden, Elizabeth Connick, Matthew Downs, Andreas Bakker, Margo R. Roberts, Carl H. June, Sayeh Jalali, Andy Lin, Rukmini Pennathur-Das, Kristen Hege	2000	186
3	Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study The Lancet Child & Adolescent Health ·Miriam Nickel, Alessandro Simonati, David Jacoby, Susanne Lezius, Dirk Kilian, Benjamin Van de Graaf, Odelya E. Pagovich, Barry E. Kosofsky, Kaleb Yohay, Matthew Downs, Peter Slasor, Temitayo Ajayi, Ronald G. Crystal, Alfried Kohlschütter, Dolan Sondhi, Angela Schulz	2018	89
4	WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study PLoS neglected tropical diseases ·Afif Ben Salah, Pierre Buffet, Gloria Morizot, Nathalie Ben Massoud, Amor Zâatour, Nissaf Ben Alaya, Nabil Bel Haj Hamida, Zaher El Ahmadi, Matthew Downs, Philip L. Smith, Koussay Dellagi, Max Grögl	2009	65
5	Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and Comprehensibility Therapeutic Innovation & Regulatory Science ·Kevin A. Buhr, Matthew Downs, Janelle Rhorer, Robin Bechhofer, Janet Wittes	2017	12
6	Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial Clinical Infectious Diseases ·Matthew B. Laurens, Randy G. Mungwira, Nginache Nampota-Nkomba, Osward M. Nyirenda, Titus Divala, Maxwell Kanjala, Felix A. Mkandawire, Lufina Tsirizani Galileya, Wongani Nyangulu, Edson Mwinjiwa, Matthew Downs, Amy Tillman, Terrie E. Taylor, Jane Mallewa, Christopher V. Plowe, Joep J. van Oosterhout, Miriam K. Laufer	2021	8
7	Current Experiences and Future Expectations for Physical Activity Participation: Perspectives of Young People with Physical Disabilities and Their Rehabilitation Clinicians Developmental Neurorehabilitation ·Matthew Downs, Joy C. MacDermid, Denise M. Connelly, Janette McDougall	2020	5
8	Outcome Measures to Assess Efficacy of Treatments for Age-Related Macular Degeneration Ophthalmology ·Janet Wittes, Matthew Downs	2009	4
9	2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer International Journal of Radiation OncologyBiologyPhysics ·Carryn M. Anderson, C.M. Lee, Deborah Saunders, A.E. Curtis, Neal Dunlap, C. Nangia, A. Lee, S.M. Gordon, P. Kovoor, Voichita Bar Ad, Abhinand Peddada, K.T. Colvett, Dukagjin Blakaj, Marcelo Bonomi, Frank Worden, J. Holmlund, J. Brill, Matthew Downs, Stephen T. Sonis, Jacob S. Buatti	2020	2
10	Tumor Outcomes of Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer International Journal of Radiation OncologyBiologyPhysics ·Carryn M. Anderson, C.M. Lee, Deborah Saunders, A.E. Curtis, Neal Dunlap, C. Nangia, A. Lee, S.M. Gordon, P. Kovoor, Voichita Bar‐Ad, Anuj V. Peddada, K.T. Colvett, Dukagjin Blakaj, Marcelo Bonomi, Frank Worden, J. Holmlund, J. Brill, Matthew Downs, Stephen T. Sonis, Jacob S. Buatti	2020	1

About Matthew Downs

Matthew Downs is a scholar working on Otorhinolaryngology, Virology, Epidemiology, Immunology and Statistics, Probability and Uncertainty, having authored 10 papers that have together received 707 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (2 papers), HIV Research and Treatment (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Oral health in cancer treatment (2 papers), Cancer Diagnosis and Treatment (2 papers), Head and Neck Cancer Studies (2 papers), Lysosomal Storage Disorders Research (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Virology (143 citations), Oncology (345 citations), Immunology (262 citations), Genetics (240 citations) and Epidemiology (137 citations). Matthew Downs has collaborated with scholars based in United States, Canada and Tunisia. Frequent co-authors include Margo R. Roberts, Peter A. Anton, Steven G. Deeks, Carl H. June, Andreas Bakker, David T. Scadden, Andy Lin, Kristen Hege, Ronald T. Mitsuyasu and Elizabeth Connick. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Blood, Clinical Infectious Diseases, Ophthalmology and The Lancet Child & Adolescent Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact